ORGS

Orgenesis Inc. [ORGS] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

ORGS Stock Summary

The Moving Average Convergence Divergence (MACD) for ORGS recently turned positive (within last 10 days).

Does not have any significance market cap ($16.84M)

Top 10 Correlated Stocks

ORGS

In the News

ORGS Financial details

Company Rating

Market Cap

16.84M

Income

2.99M

Revenue

27.75M

Book val./share

Cash/share

Dividend

Dividend %

Employees

167

Optionable

Shortable

Yes

Earnings

08 May 2024

P/E

3.73

Forward P/E

PEG

-0.34

P/S

0.44

P/B

0.9

P/C

P/FCF

-0.37

Quick Ratio

0.56

Current Ratio

0.61

Debt / Equity

LT Debt / Equity

EPS (TTM)

0.07

EPS next Y

EPS next Q

EPS this Y

-35.14%

EPS next Y

EPS next 5Y

EPS last 5Y

-18.92%

Revenue last 5Y

14.07%

Revenue Q/Q

-98.42%

EPS Q/Q

-386.67%

SMA20

5.16%

SMA50

40.52%

SMA100

-66.18%

Inst Own

Inst Trans

ROA

ROE

13%

ROC

-0.27%

Gross Margin

78%

Oper. Margin

-30%

Profit Margin

11%

Payout

Shs Outstand

Shs Float

Target Price

52W Range

0.25-1.5

52W High

52W Low

RSI

65.61

Rel Volume

0.06

Avg Volume

251.16K

Volume

14.83K

Perf Week

30.3%

Perf Month

14.06%

Perf Quarter

-69.29%

Perf Half Y

-72.78%

Beta

1.098

Volatility

0.22%, 0.2%

Prev Close

29.52%

Price

2.15

Change

29.52%

Something similar

Top by Market Cap

Same Sector

Top Correlated Stocks

Similar Market Cap

Company Profile

Volume Average 251.16K
Market Capitalization 16.84M
Employee 167
CEO Ms. Vered Caplan M.Sc.
Headquarters Germantown,MD,US
IPO Date 2012-03-13
Website https://www.orgenesis.com

Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient at their point of care for treatment of the patient. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is based in Germantown, Maryland.